ITC to investigate Alvotech’s Humira biosimilar

27-01-2022

Alex Baldwin

ITC to investigate Alvotech’s Humira biosimilar

Mark Van Scyoc / Shutterstock.com

The US International Trade Commission (ITC) will investigate whether drug manufacturers used trade secrets to develop a biosimilar of AbbVie’s Humira (adalimumab).


ITC, Humira, Alvotech, AbbVie, Section 337, biosimilars

LSIPR